Indicator type;Branch of activity;Total
Number of companies carrying out R&D in Biotechnology;Total companies;1,602
Number of companies carrying out R&D in Biotechnology;Agriculture;106
Number of companies carrying out R&D in Biotechnology;Industry and Construction;414
Number of companies carrying out R&D in Biotechnology;Services;1,082
% Companies by type of biotechnology used: Genetic Code;Total companies;28.8
% Companies by type of biotechnology used: Genetic Code;Agriculture;21.8
% Companies by type of biotechnology used: Genetic Code;Industry and Construction;16.3
% Companies by type of biotechnology used: Genetic Code;Services;34.3
% Companies by type of biotechnology used: Functional Units;Total companies;38.9
% Companies by type of biotechnology used: Functional Units;Agriculture;12.6
% Companies by type of biotechnology used: Functional Units;Industry and Construction;34.9
% Companies by type of biotechnology used: Functional Units;Services;43.0
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Total companies;21.5
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Agriculture;9.9
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Industry and Construction;19.3
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Services;23.5
% Companies by type of biotechnology used: Bioprocesses;Total companies;49.5
% Companies by type of biotechnology used: Bioprocesses;Agriculture;44.1
% Companies by type of biotechnology used: Bioprocesses;Industry and Construction;73.7
% Companies by type of biotechnology used: Bioprocesses;Services;40.8
% Companies by type of biotechnology used: Subcellular Organisms;Total companies;8.7
% Companies by type of biotechnology used: Subcellular Organisms;Agriculture;1.0
% Companies by type of biotechnology used: Subcellular Organisms;Industry and Construction;6.3
% Companies by type of biotechnology used: Subcellular Organisms;Services;10.3
% Companies by type of biotechnology used: Bioinformatics;Total companies;26.9
% Companies by type of biotechnology used: Bioinformatics;Agriculture;4.8
% Companies by type of biotechnology used: Bioinformatics;Industry and Construction;11.9
% Companies by type of biotechnology used: Bioinformatics;Services;34.7
% Companies by type of biotechnology used: Nanobiotechnology;Total companies;11.8
% Companies by type of biotechnology used: Nanobiotechnology;Agriculture;1.3
% Companies by type of biotechnology used: Nanobiotechnology;Industry and Construction;6.0
% Companies by type of biotechnology used: Nanobiotechnology;Services;15.1
% Companies by type of biotechnology used: Other;Total companies;18.0
% Companies by type of biotechnology used: Other;Agriculture;35.0
% Companies by type of biotechnology used: Other;Industry and Construction;12.2
% Companies by type of biotechnology used: Other;Services;18.6
Companies in which biotechnology activities are: Main and/or exclusive;Total companies;773
Companies in which biotechnology activities are: Main and/or exclusive;Agriculture;23
Companies in which biotechnology activities are: Main and/or exclusive;Industry and Construction;106
Companies in which biotechnology activities are: Main and/or exclusive;Services;645
Companies in which biotechnology activities are: A secondary business line;Total companies;279
Companies in which biotechnology activities are: A secondary business line;Agriculture;27
Companies in which biotechnology activities are: A secondary business line;Industry and Construction;94
Companies in which biotechnology activities are: A secondary business line;Services;157
Companies in which biotechnology activities are: A necessary tool for production;Total companies;550
Companies in which biotechnology activities are: A necessary tool for production;Agriculture;56
Companies in which biotechnology activities are: A necessary tool for production;Industry and Construction;214
Companies in which biotechnology activities are: A necessary tool for production;Services;281
% Companies by final application areas of biotechnology use: Human Health;Total companies;48.4
% Companies by final application areas of biotechnology use: Human Health;Agriculture;1.9
% Companies by final application areas of biotechnology use: Human Health;Industry and Construction;25.8
% Companies by final application areas of biotechnology use: Human Health;Services;61.5
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Total companies;19.1
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Agriculture;29.9
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Industry and Construction;16.2
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Services;19.2
% Companies by final application areas of biotechnology use: Food Products;Total companies;28.9
% Companies by final application areas of biotechnology use: Food Products;Agriculture;32.9
% Companies by final application areas of biotechnology use: Food Products;Industry and Construction;46.0
% Companies by final application areas of biotechnology use: Food Products;Services;22.0
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Total companies;24.8
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Agriculture;61.7
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Industry and Construction;24.5
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Services;21.3
% Companies by final application areas of biotechnology use: Environment;Total companies;18.2
% Companies by final application areas of biotechnology use: Environment;Agriculture;14.5
% Companies by final application areas of biotechnology use: Environment;Industry and Construction;18.2
% Companies by final application areas of biotechnology use: Environment;Services;18.6
% Companies by final application areas of biotechnology use: Industry;Total companies;13.5
% Companies by final application areas of biotechnology use: Industry;Agriculture;5.8
% Companies by final application areas of biotechnology use: Industry;Industry and Construction;14.9
% Companies by final application areas of biotechnology use: Industry;Services;13.7
R&D personnel in Biotechnology (PP);Total companies;19,307
R&D personnel in Biotechnology (PP);Agriculture;1,164
R&D personnel in Biotechnology (PP);Industry and Construction;5,254
R&D personnel in Biotechnology (PP);Services;12,889
R&D personnel in Biotechnology (PP): Research personnel;Total companies;10,779
R&D personnel in Biotechnology (PP): Research personnel;Agriculture;310
R&D personnel in Biotechnology (PP): Research personnel;Industry and Construction;2,465
R&D personnel in Biotechnology (PP): Research personnel;Services;8,004
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Total companies;8,528
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Agriculture;854
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Industry and Construction;2,789
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Services;4,885
R&D personnel in Biotechnology (PP). Women;Total companies;11,155
R&D personnel in Biotechnology (PP). Women;Agriculture;562
R&D personnel in Biotechnology (PP). Women;Industry and Construction;2,961
R&D personnel in Biotechnology (PP). Women;Services;7,632
R&D personnel in Biotechnology (PP). Women: Research personnel;Total companies;5,934
R&D personnel in Biotechnology (PP). Women: Research personnel;Agriculture;121
R&D personnel in Biotechnology (PP). Women: Research personnel;Industry and Construction;1,312
R&D personnel in Biotechnology (PP). Women: Research personnel;Services;4,500
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Total companies;5,222
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Agriculture;441
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Industry and Construction;1,649
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Services;3,132
R&D personnel in Biotechnology (FTE);Total companies;14,093.7
R&D personnel in Biotechnology (FTE);Agriculture;773.9
R&D personnel in Biotechnology (FTE);Industry and Construction;3,606.1
R&D personnel in Biotechnology (FTE);Services;9,713.7
R&D personnel in Biotechnology (FTE): Research personnel;Total companies;8,073.8
R&D personnel in Biotechnology (FTE): Research personnel;Agriculture;219.3
R&D personnel in Biotechnology (FTE): Research personnel;Industry and Construction;1,751.9
R&D personnel in Biotechnology (FTE): Research personnel;Services;6,102.6
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Total companies;6,019.9
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Agriculture;554.6
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Industry and Construction;1,854.2
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Services;3,611.1
R&D personnel in Biotechnology (FTE). Women;Total companies;8,305.8
R&D personnel in Biotechnology (FTE). Women;Agriculture;401.9
R&D personnel in Biotechnology (FTE). Women;Industry and Construction;2,140.3
R&D personnel in Biotechnology (FTE). Women;Services;5,763.6
R&D personnel in Biotechnology (FTE). Women: Research personnel;Total companies;4,482.6
R&D personnel in Biotechnology (FTE). Women: Research personnel;Agriculture;94.4
R&D personnel in Biotechnology (FTE). Women: Research personnel;Industry and Construction;954.2
R&D personnel in Biotechnology (FTE). Women: Research personnel;Services;3,434.0
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Total companies;3,823.2
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Agriculture;307.6
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Industry and Construction;1,186.0
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Services;2,329.6
Expenditure on internal R&D in Biotechnology (thousands of euros);Total companies;1,462,695
Expenditure on internal R&D in Biotechnology (thousands of euros);Agriculture;50,039
Expenditure on internal R&D in Biotechnology (thousands of euros);Industry and Construction;460,648
Expenditure on internal R&D in Biotechnology (thousands of euros);Services;952,007
1) By type of expenditure: Current expenditure;Total companies;1,347,574
1) By type of expenditure: Current expenditure;Agriculture;47,888
1) By type of expenditure: Current expenditure;Industry and Construction;428,926
1) By type of expenditure: Current expenditure;Services;870,760
1.1) Labour expenditure of research personnel;Total companies;470,714
1.1) Labour expenditure of research personnel;Agriculture;13,630
1.1) Labour expenditure of research personnel;Industry and Construction;137,896
1.1) Labour expenditure of research personnel;Services;319,187
1.2) Labour expenditure of technical and auxiliary personnel;Total companies;258,791
1.2) Labour expenditure of technical and auxiliary personnel;Agriculture;18,864
1.2) Labour expenditure of technical and auxiliary personnel;Industry and Construction;97,459
1.2) Labour expenditure of technical and auxiliary personnel;Services;142,468
1.3) Other current expenditure;Total companies;618,069
1.3) Other current expenditure;Agriculture;15,394
1.3) Other current expenditure;Industry and Construction;193,571
1.3) Other current expenditure;Services;409,105
2) By type of expenditure: Capital expenditure;Total companies;115,121
2) By type of expenditure: Capital expenditure;Agriculture;2,151
2) By type of expenditure: Capital expenditure;Industry and Construction;31,722
2) By type of expenditure: Capital expenditure;Services;81,247
2.1) Land and buildings;Total companies;21,877
2.1) Land and buildings;Agriculture;787
2.1) Land and buildings;Industry and Construction;10,015
2.1) Land and buildings;Services;11,075
2.2) Equipment and tools;Total companies;54,592
2.2) Equipment and tools;Agriculture;1,251
2.2) Equipment and tools;Industry and Construction;18,732
2.2) Equipment and tools;Services;34,608
2.3) Acquisition of specific R&D software;Total companies;4,673
2.3) Acquisition of specific R&D software;Agriculture;70
2.3) Acquisition of specific R&D software;Industry and Construction;1,097
2.3) Acquisition of specific R&D software;Services;3,506
2.4) Other R&D-specific IP products;Total companies;33,978
2.4) Other R&D-specific IP products;Agriculture;43
2.4) Other R&D-specific IP products;Industry and Construction;1,877
2.4) Other R&D-specific IP products;Services;32,058
1.1) By origin of funds: Own funds;Total companies;1,013,505
1.1) By origin of funds: Own funds;Agriculture;41,821
1.1) By origin of funds: Own funds;Industry and Construction;403,162
1.1) By origin of funds: Own funds;Services;568,522
1.2) By origin of funds: Funds from the Business sector;Total companies;206,072
1.2) By origin of funds: Funds from the Business sector;Agriculture;4,418
1.2) By origin of funds: Funds from the Business sector;Industry and Construction;26,556
1.2) By origin of funds: Funds from the Business sector;Services;175,098
1.3) By origin of funds: Funds from the Public Administration sector;Total companies;158,706
1.3) By origin of funds: Funds from the Public Administration sector;Agriculture;2,963
1.3) By origin of funds: Funds from the Public Administration sector;Industry and Construction;21,927
1.3) By origin of funds: Funds from the Public Administration sector;Services;133,817
1.4) By origin of funds: Funds from the Higher Education sector;Total companies;615
1.4) By origin of funds: Funds from the Higher Education sector;Agriculture;127
1.4) By origin of funds: Funds from the Higher Education sector;Industry and Construction;18
1.4) By origin of funds: Funds from the Higher Education sector;Services;470
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Total companies;9,828
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Agriculture;0
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Industry and Construction;0
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Services;9,828
1.6) By origin of funds: Funds from the rest of the world;Total companies;73,969
1.6) By origin of funds: Funds from the rest of the world;Agriculture;711
1.6) By origin of funds: Funds from the rest of the world;Industry and Construction;8,986
1.6) By origin of funds: Funds from the rest of the world;Services;64,272
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Total companies;96,238
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Agriculture;691
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Industry and Construction;51,441
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Services;44,106
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Total companies;65,364
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Agriculture;302
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Industry and Construction;42,505
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Services;22,557
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Total companies;30,874
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Agriculture;389
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Industry and Construction;8,936
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Services;21,549
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Total companies;46.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Agriculture;34.5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Industry and Construction;35.2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Services;51.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Total companies;17.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Agriculture;21.7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Industry and Construction;19.8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Services;15.7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Total companies;25.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Agriculture;31.0
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Industry and Construction;29.0
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Services;24.2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Total companies;13.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Agriculture;13.6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Industry and Construction;12.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Services;13.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Total companies;18.6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Agriculture;14.0
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Industry and Construction;11.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Services;21.6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Total companies;17.3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Agriculture;10.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Industry and Construction;11.7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Services;20.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Total companies;20.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Agriculture;20.0
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Industry and Construction;17.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Services;20.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Total companies;47.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Agriculture;43.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Industry and Construction;43.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Services;49.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Total companies;53.7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Agriculture;48.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Industry and Construction;53.0
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Services;54.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Total companies;21.6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Agriculture;23.7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Industry and Construction;17.8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Services;22.9
% Companies with international revenues related to biotechnology activities;Total companies;22.2
% Companies with international revenues related to biotechnology activities;Agriculture;8.1
% Companies with international revenues related to biotechnology activities;Industry and Construction;24.4
% Companies with international revenues related to biotechnology activities;Services;22.7
% Companies representing international revenues related to biotechnology activities;Total companies;2.2
% Companies representing international revenues related to biotechnology activities;Agriculture;0.6
% Companies representing international revenues related to biotechnology activities;Industry and Construction;2.1
% Companies representing international revenues related to biotechnology activities;Services;2.9
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Total companies;55.2
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Agriculture;64.8
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Industry and Construction;57.1
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Services;44.8
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Total companies;44.8
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Agriculture;35.2
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Industry and Construction;42.9
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Services;55.2
% International revenues related to biotechnology activities by classification: International trade in goods and services;Total companies;87.2
% International revenues related to biotechnology activities by classification: International trade in goods and services;Agriculture;95.7
% International revenues related to biotechnology activities by classification: International trade in goods and services;Industry and Construction;90.0
% International revenues related to biotechnology activities by classification: International trade in goods and services;Services;71.8
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total companies;4.6
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Agriculture;4.3
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Industry and Construction;2.9
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Services;13.5
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Total companies;4.3
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Agriculture;0.0
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Industry and Construction;4.0
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Services;6.1
% International revenues related to biotechnology activities by classification: Other;Total companies;3.9
% International revenues related to biotechnology activities by classification: Other;Agriculture;0.0
% International revenues related to biotechnology activities by classification: Other;Industry and Construction;3.1
% International revenues related to biotechnology activities by classification: Other;Services;8.6